Found: 19
Select item for more details and to access through your institution.
Carbapenems vs β-Lactam Monotherapy or Combination Therapy for the Treatment of Complicated Intra-abdominal Infections: Systematic Review and Meta-analysis of Randomized Controlled Trials.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 10, p. N.PAG, doi. 10.1093/ofid/ofz394
- By:
- Publication type:
- Article
Nivolumab Versus Sorafenib as First-Line Therapy for Advanced Hepatocellular Carcinoma: A Cost-Effectiveness Analysis.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.906956
- By:
- Publication type:
- Article
Rapid and sensitive detection of methicillin-resistant Staphylococcus aureus through the RPA-PfAgo system.
- Published in:
- Frontiers in Microbiology, 2024, p. 1, doi. 10.3389/fmicb.2024.1422574
- By:
- Publication type:
- Article
Epidemiology, evolutionary origin, and malaria‐induced positive selection effects of G6PD‐deficient alleles in Chinese populations.
- Published in:
- Molecular Genetics & Genomic Medicine, 2020, v. 8, n. 12, p. 1, doi. 10.1002/mgg3.1540
- By:
- Publication type:
- Article
Cost-effectiveness of sacituzumab govitecan in hormone receptor-positive/ human epidermal growth factor receptor 2-negative metastatic breast cancer.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1162360
- By:
- Publication type:
- Article
Cost-effectiveness of trastuzumab deruxtecan for previously treated HER2-low advanced breast cancer.
- Published in:
- PLoS ONE, 2023, v. 18, n. 8, p. 1, doi. 10.1371/journal.pone.0290507
- By:
- Publication type:
- Article
Cost‑effectiveness analysis of tislelizumab plus chemotherapy in Chinese patients with advanced or metastatic oesophageal squamous cell carcinoma.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-68399-3
- By:
- Publication type:
- Article
First-line serplulimab plus chemotherapy versus chemotherapy in PD-L1-positive esophageal squamous-cell carcinoma: a cost-effectiveness analysis.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-65474-7
- By:
- Publication type:
- Article
Immune checkpoint inhibitors in first-line therapies of metastatic or early triple-negative breast cancer: a systematic review and network meta-analysis.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1137464
- By:
- Publication type:
- Article
2D Film‐Like Magnetic SERS Tag with Enhanced Capture and Detection Abilities for Immunochromatographic Diagnosis of Multiple Bacteria (Small 22/2024).
- Published in:
- Small, 2024, v. 20, n. 22, p. 1, doi. 10.1002/smll.202470171
- By:
- Publication type:
- Article
2D Film‐Like Magnetic SERS Tag with Enhanced Capture and Detection Abilities for Immunochromatographic Diagnosis of Multiple Bacteria.
- Published in:
- Small, 2024, v. 20, n. 22, p. 1, doi. 10.1002/smll.202310014
- By:
- Publication type:
- Article
Single-nucleotide polymorphisms of artemisinin resistance-related Pfubp1 and Pfap2mu genes in Bioko Island, Equatorial Guinea from 2018 to 2020.
- Published in:
- Chinese Journal of Schistosomiasis Control, 2023, v. 35, n. 6, p. 557, doi. 10.16250/j.32.1374.2023180
- By:
- Publication type:
- Article
Cost-effectiveness of cemiplimab plus chemotherapy versus chemotherapy for the treatment of advanced non-small cell lung cancer.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1113374
- By:
- Publication type:
- Article
Pembrolizumab vs cemiplimab for the treatment of advanced non-small cell lung cancer with PD-L1 expression levels of at least 50%: A network meta-analysis and costeffectiveness analysis.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.878054
- By:
- Publication type:
- Article
Adverse events associated with immune checkpoint inhibitors in non-small cell lung cancer: a safety analysis of clinical trials and FDA pharmacovigilance system.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1396752
- By:
- Publication type:
- Article
Panax notoginseng saponins ameliorate cisplatin‐induced mitochondrial injury via the HIF‐1α/mitochondria/ROS pathway.
- Published in:
- FEBS Open Bio, 2020, v. 10, n. 1, p. 118, doi. 10.1002/2211-5463.12760
- By:
- Publication type:
- Article
New Approach for Targeted Treatment of Mild COVID-19 by Honeysuckle through Network Pharmacology Analysis.
- Published in:
- Computational & Mathematical Methods in Medicine, 2022, p. 1, doi. 10.1155/2022/9604456
- By:
- Publication type:
- Article
Atezolizumab plus bevacizumab versus nivolumab as first‐line treatment for advanced or unresectable hepatocellular carcinoma: A cost‐effectiveness analysis.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 22, p. 3995, doi. 10.1002/cncr.34457
- By:
- Publication type:
- Article
Nivolumab plus ipilimumab versus the EXTREME regimen in recurrent/metastatic squamous cell carcinoma of the head and neck: a cost-effectiveness analysis.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-57277-7
- By:
- Publication type:
- Article